| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| A Gerdelat-Mas, M Simonetta-Moreau, C Thalamas, F Ory-Magne, T Slaoui, O Rascol, C Brefel-Courbo. Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study. Journal of neurology, neurosurgery, and psychiatry. vol 78. issue 10. 2007-10-01. PMID:17504881. |
experimental data have indicated the involvement of basal ganglia and dopaminergic pathways in central nociceptive processing. |
2007-10-01 |
2023-08-12 |
Not clear |
| James M Tepper, Christian R Le. GABAergic control of substantia nigra dopaminergic neurons. Progress in brain research. vol 160. 2007-09-28. PMID:17499115. |
the data reviewed in this chapter have made it increasingly clear that in addition to the effects that nigral gabaergic output neurons have on their target nuclei outside of the basal ganglia, local interactions between gabaergic projection neurons and dopaminergic neurons are crucially important to the functioning of the nigral dopaminergic neurons. |
2007-09-28 |
2023-08-12 |
Not clear |
| O Hikosak. GABAergic output of the basal ganglia. Progress in brain research. vol 160. 2007-09-28. PMID:17499116. |
to achieve such a goal, however, the basal ganglia need to be trained to optimize their outputs with the aid of cortical inputs carrying sensorimotor and cognitive information and dopaminergic inputs carrying reward-related information. |
2007-09-28 |
2023-08-12 |
Not clear |
| Philippe Huot, André Paren. Dopaminergic neurons intrinsic to the striatum. Journal of neurochemistry. vol 101. issue 6. 2007-08-16. PMID:17286588. |
the striatum -- the largest integrative component of the basal ganglia -- harbors a population of neurons that express the enzyme tyrosine hydroxylase (th), a faithful marker of dopaminergic neurons. |
2007-08-16 |
2023-08-12 |
Not clear |
| Marko Schirmer, Alexander Kaiser, Alina Lessenich, Sven Lindemann, Maren Fedrowitz, Manuela Gernert, Wolfgang Lösche. Auditory and vestibular defects and behavioral alterations after neonatal administration of streptomycin to Lewis rats: Similarities and differences to the circling (ci2/ci2) Lewis rat mutant. Brain research. vol 1155. 2007-08-13. PMID:17493596. |
based on previous observations in the circling (ci2/ci2) lewis (lew) rat mutant, a spontaneous mutation leading to hair cell loss, deafness, impairment of vestibular functions, lateralized circling, hyperactivity and alterations in the nigrostriatal dopamine system, we have recently hypothesized that vestibular defects during postnatal development, independent of whether induced or inherited, lead to secondary changes in the dopaminergic system within the basal ganglia, which would be a likely explanation for the typical behavioral phenotype seen in such models. |
2007-08-13 |
2023-08-12 |
rat |
| Finlay D Dic. Parkinson's disease and pesticide exposures. British medical bulletin. vol 79-80. 2007-07-27. PMID:17242039. |
idiopathic parkinson's disease (pd) is a neurodegenerative disorder in which loss of dopaminergic neurons in the basal ganglia leads to tremor, bradykinesia, rigidity and postural instability. |
2007-07-27 |
2023-08-12 |
Not clear |
| I G Sil'ki. [Role of dopamine-dependent negative feedback in the hippocampal--basal ganglia--thalamo---hippocampal loop in response decrement]. Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova. vol 93. issue 3. 2007-07-16. PMID:17598465. |
the mechanism of response decrement in hippocampal and dopaminergic neurons on repeating stimuli based on the dopamine-dependent negative feedback in the hippocampal--basal ganglia--thalamo--hippocampal loop is suggested. |
2007-07-16 |
2023-08-12 |
Not clear |
| Michael G Kaplitt, Andrew Feigin, Chengke Tang, Helen L Fitzsimons, Paul Mattis, Patricia A Lawlor, Ross J Bland, Deborah Young, Kristin Strybing, David Eidelberg, Matthew J Durin. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet (London, England). vol 369. issue 9579. 2007-07-03. PMID:17586305. |
dopaminergic neuronal loss in parkinson's disease leads to changes in the circuitry of the basal ganglia, such as decreased inhibitory gabaergic input to the subthalamic nucleus. |
2007-07-03 |
2023-08-12 |
Not clear |
| Isabella Silki. A hypothetical role of cortico-basal ganglia-thalamocortical loops in visual processing. Bio Systems. vol 89. issue 1-3. 2007-06-26. PMID:17204363. |
visual excitation of the prefrontal cortex and hippocampus (via the thalamus), their cooperation in control of the basal ganglia and dopaminergic cell firing, and simultaneous modulation of activity in diverse cortico-basal ganglia-thalamocortical loops is proposed to underlie top-down attentional effects. |
2007-06-26 |
2023-08-12 |
Not clear |
| Henry J Waldvogel, Kristin Baer, Kathryn L Allen, Mark I Rees, Richard L M Faul. Glycine receptors in the striatum, globus pallidus, and substantia nigra of the human brain: an immunohistochemical study. The Journal of comparative neurology. vol 502. issue 6. 2007-06-26. PMID:17444490. |
our results demonstrate the precise cellular and subcellular localization of glyrs in the human basal ganglia and suggest that glycinergic receptors may play an important complementary role to other inhibitory receptors in modulating cholinergic, dopaminergic, and gabaergic neuronal pathways in the basal ganglia. |
2007-06-26 |
2023-08-12 |
human |
| Diane T Stephenson, Mary Abigail Childs, Qiu Li, Santos Carvajal-Gonzalez, Alan Opsahl, Mark Tengowski, Martin D Meglasson, Kalpana Merchant, Marina E Embor. Differential loss of presynaptic dopaminergic markers in Parkinsonian monkeys. Cell transplantation. vol 16. issue 3. 2007-06-21. PMID:17503735. |
mptp treatment induced a significant decline of dopaminergic immunoreactive fiber and terminal density in the basal ganglia. |
2007-06-21 |
2023-08-12 |
monkey |
| Diane T Stephenson, Mary Abigail Childs, Qiu Li, Santos Carvajal-Gonzalez, Alan Opsahl, Mark Tengowski, Martin D Meglasson, Kalpana Merchant, Marina E Embor. Differential loss of presynaptic dopaminergic markers in Parkinsonian monkeys. Cell transplantation. vol 16. issue 3. 2007-06-21. PMID:17503735. |
these results illustrate that neurotoxic injury of the dopamine system in primates leads to altered and differential expression of presynaptic dopaminergic markers in the basal ganglia and that expression of such markers may be modulated by l-dopa therapy. |
2007-06-21 |
2023-08-12 |
monkey |
| Kazuhiro Shishida, Akira Hashizume, Keiichi Onoda, Yasumasa Okamoto, Shigeto Yamawak. Enhanced reactivity and delayed recovery of sensorimotor cortex in the novelty seeking personality. Neuropsychobiology. vol 54. issue 4. 2007-06-13. PMID:17337915. |
the novelty seeking (ns) personality trait is hypothesized to be associated with high cortical reactivity, poor inhibitory control and/or varied dopaminergic neurotransmission in the basal ganglia. |
2007-06-13 |
2023-08-12 |
Not clear |
| Kazuhiro Shishida, Akira Hashizume, Keiichi Onoda, Yasumasa Okamoto, Shigeto Yamawak. Enhanced reactivity and delayed recovery of sensorimotor cortex in the novelty seeking personality. Neuropsychobiology. vol 54. issue 4. 2007-06-13. PMID:17337915. |
these oscillatory changes are also believed to be affected by the status of the basal ganglia and by dopaminergic functions. |
2007-06-13 |
2023-08-12 |
Not clear |
| Helga Nagy, Szabolcs Kéri, Catherine E Myers, György Benedek, Daphna Shohamy, Mark A Gluc. Cognitive sequence learning in Parkinson's disease and amnestic mild cognitive impairment: Dissociation between sequential and non-sequential learning of associations. Neuropsychologia. vol 45. issue 7. 2007-06-01. PMID:17188311. |
evidence suggests that dopaminergic mechanisms in the basal ganglia (bg) are important in the learning of sequential associations. |
2007-06-01 |
2023-08-12 |
Not clear |
| David A Price, William A Owens, Georgianna G Gould, Alan Frazer, James L Roberts, Lynette C Daws, Andrea Giuffrid. CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum. Journal of neurochemistry. vol 101. issue 2. 2007-06-01. PMID:17250681. |
cannabinoid drugs are known to affect dopaminergic neurotransmission in the basal ganglia circuitry. |
2007-06-01 |
2023-08-12 |
mouse |
| Giselle M Petzinger, John P Walsh, Garnik Akopian, Elizabeth Hogg, Avery Abernathy, Pablo Arevalo, Patty Turnquist, Marta Vucković, Beth E Fisher, Daniel M Togasaki, Michael W Jakowe. Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 27. issue 20. 2007-05-31. PMID:17507552. |
effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. |
2007-05-31 |
2023-08-12 |
mouse |
| Shaji Theodore, Wayne A Cass, Avindra Nath, William F Marago. Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration. Current HIV research. vol 5. issue 3. 2007-05-29. PMID:17504172. |
understanding the interaction of tat and ma in the basal ganglia and the resultant injury to the dopaminergic system in rodent models as well as cell culture will shed light on the dopaminergic pathology occurring in hiv-1 infected-ma abusers. |
2007-05-29 |
2023-08-12 |
Not clear |
| A Coban, N M Filipo. Dopaminergic toxicity associated with oral exposure to the herbicide atrazine in juvenile male C57BL/6 mice. Journal of neurochemistry. vol 100. issue 5. 2007-04-02. PMID:17217422. |
together, these data indicate that, in the juvenile male c57bl/6 mouse, the neurotoxic effects of atr appear to cause transient neurochemical alterations, whereas the loss of th+ neurons appears to be persistent, possibly confined to basal ganglia dopaminergic neurons, but not exclusive to the snpc. |
2007-04-02 |
2023-08-12 |
mouse |
| Clare J Fowle. Update on the neurology of Parkinson's disease. Neurourology and urodynamics. vol 26. issue 1. 2007-03-27. PMID:17080417. |
bladder symptoms of neurological origin are likely in a patient who has had treated motor symptoms for some years and in whom the ongoing neuropathology has progressed beyond involvement of the basal ganglia, so that symptoms due to cortical dysfunction as well as the adverse effects of dopaminergic medication are also confounding factors. |
2007-03-27 |
2023-08-12 |
Not clear |